| Professional Services Industry | Industrials Sector | David Lontini CEO | XFRA Exchange | IL0011336851 ISIN |
| IL Country | 85 Employees | - Last Dividend | 25 Nov 2022 Last Split | - IPO Date |
Check-Cap Ltd. is a pioneering clinical stage medical diagnostics company that specializes in innovative capsule-based screening technologies designed to enhance patient health and diagnostics capabilities. Established in 2004, the company is headquartered in Isfiya, Israel and strives to revolutionize medical screening processes through its cutting-edge products. With a focus on non-invasive diagnostic solutions, Check-Cap aims to improve early detection and management of various medical conditions, particularly those within the gastrointestinal realm.
This advanced imaging technology utilizes ingestible capsules to capture high-resolution images of the digestive tract. Designed to provide non-invasive and thorough examination, this product can help detect abnormalities and diseases early on, which is critical for effective treatment.
Check-Cap offers specialized screening tools aimed at identifying potential issues within the gastrointestinal system. These tools combine advanced imaging and diagnostic techniques to give healthcare providers essential insights into patients' health.
Through sophisticated data analytics, Check-Cap interprets the images and provides comprehensive reports that aid physicians in making informed decisions regarding patient care. This service ensures timely and accurate diagnoses, facilitating better patient outcomes.
Dedication to innovation is at the heart of Check-Cap's mission. The company actively engages in research and development to refine existing technologies and explore new applications for capsule-based diagnostics, ensuring they remain at the forefront of medical advancements.